Cyclerion Therapeutics, Inc (CYCN)

Etorro trading 970x250
Cyclerion Therapeutics, Inc (CYCN) Logo

About Cyclerion Therapeutics, Inc

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase II trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Alzheimer’s disease with vascular pathology (ADv); Olinciguat, an orally administered vascular soluble guanylate cyclase stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142

Cyclerion Therapeutics, Inc News and around…

Latest news about Cyclerion Therapeutics, Inc (CYCN) common stock and company :

David Greenspan’s Slate Path Capital is Buying Coinbase, Stitch Fix, and More
11 Oct, 2021 Yahoo! Finance

In this article, we discuss the top stocks recently acquired by David Greenspan’s Slate Path Capital according to analysts. If you want to skip our detailed analysis of Greenspan’s history, investment philosophy, and hedge fund performance, go directly to David Greenspan’s Slate Path Capital is Buying These 5 Stocks. David Greenspan instilled his efforts at […]

Is Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) Popular Amongst Institutions?
10 Oct, 2021 Yahoo! Finance

Every investor in Cyclerion Therapeutics, Inc. ( NASDAQ:CYCN ) should be aware of the most powerful shareholder groups...

Analysts Forecast 21% Upside For IEIH
30 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Evolved US.

Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
24 Sep, 2021 FinancialContent

Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ:TENB) from Hold to Buy. In the second quarter, Tenable ...

Cyclerion Announces Publication of Preclinical Data Demonstrating Reduction in Neuroinflammation by Brain-Penetrant sGC Stimulator
22 Sep, 2021 FinancialContent

Company developing lead sGC stimulator, CY6463, in multiple CNS diseases associated with cognitive impairment

Cyclerion Announces Publication of Preclinical Data Demonstrating Reduction in Neuroinflammation by Brain-Penetrant sGC Stimulator
22 Sep, 2021 Yahoo! Finance

Company developing lead sGC stimulator, CY6463, in multiple CNS diseases associated with cognitive impairmentCAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing treatments that restore cognitive function, today announced a publication demonstrating that administration of a small molecule soluble guanylate cyclase (sGC) stimulator reduced markers associated with neuroinflammation in multiple precli

Cyclerion Therapeutics to Participate in Two Upcoming Investor Conferences
08 Sep, 2021 FinancialContent
Cyclerion Therapeutics (NASDAQ:CYCN) Has Debt But No Earnings; Should You Worry?
26 Aug, 2021 Yahoo! Finance

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer’s Disease Summit
23 Aug, 2021 FinancialContent

Presentation to highlight the potential of early clinical assessment of biomarkers to drive development of Alzheimer’s disease therapies

12 Health Care Stocks Moving In Monday's After-Market Session
16 Aug, 2021 FinancialContent

Gainers Strata Skin Sciences (NASDAQ:SSKN) stock increased by 11.27% to $1.48 during Monday's after-market session. Today's trading ...

70 Biggest Movers From Yesterday
30 Jul, 2021 FinancialContent

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently ...

Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
29 Jul, 2021 FinancialContent
75 Biggest Movers From Friday
26 Jul, 2021 FinancialContent

Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired ...

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
25 Jul, 2021 FinancialContent

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism ...

Why Cyclerion Therapeutics Shares Are Moving Today
23 Jul, 2021 FinancialContent

Cyclerion Therapeutics Inc (NASDAQ: CYCN) shares are trading higher Friday morning after the company announced it will present a trial ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
23 Jul, 2021 FinancialContent

Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 56.69% to $5.97 during Friday's pre-market session. ...

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
23 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
23 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're gearing up for one final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.

32 Stocks Moving in Friday's Pre-Market Session
23 Jul, 2021 FinancialContent

Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported ...

12 Stocks Moving In Thursday's After-Hours Session
22 Jul, 2021 FinancialContent

Gainers Twitter (NYSE: TWTR) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results ...

Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer’s Disease with Vascular Pathology at the Alzheimer’s Association International Conferen
22 Jul, 2021 FinancialContent

Research to be presented highlighting potential of neuropsychological biomarkers to guide the clinical development of Cyclerion’s investigational therapeutics

Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer’s Disease with Vascular Pathology at the Alzheimer’s Association International Conference 2021 (AAIC)
22 Jul, 2021 Yahoo! Finance

Research to be presented highlighting potential of neuropsychological biomarkers to guide the clinical development of Cyclerion’s investigational therapeuticsCAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced that it will present clinical trial design for a Phase 2a study of its lead development candidate, CY6463, in particip

First Week of CYCN September 17th Options Trading
16 Jul, 2021 FinancialContent

Investors in Cyclerion Therapeutics Inc (CYCN) saw new options begin trading this week, for the September 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CYCN options chain for the new September 17th contracts and identified one put and one call contract of particular interest.

Cyclerion Therapeutics' (NASDAQ:CYCN) Shareholders Are Down 31% On Their Shares
12 Jul, 2021 Yahoo! Finance

It is a pleasure to report that the Cyclerion Therapeutics, Inc. ( NASDAQ:CYCN ) is up 34% in the last quarter. But...

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
09 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Cyclerion Recruits Beacon Biosignals To Identify Disease-Relevant EEG Neurological Biomarkers
09 Jul, 2021 FinancialContent

Cyclerion Therapeutics Inc(NASDAQ: CYCN) andBeacon Biosignalshave expanded strategic partnershipsbetween the ...

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership
08 Jul, 2021 Yahoo! Finance

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies. This collaboration is expected to identify disease-relevant biomarkers to refine patient selection and endpoints to guide the clinical development of Cyclerion's investigational therapeutics for neurological diseases associated with cognitive impairment.

Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership
08 Jul, 2021 FinancialContent

Beacon Biosignals and Cyclerion to extend and expand partnership on data collection and analytics strategy to facilitate development of Cyclerion investigational therapeutics for neurological diseases associated with cognitive impairment

12 Health Care Stocks Moving In Tuesday's Intraday Session
15 Jun, 2021 FinancialContent

Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. ...

Best Penny Stocks on Reddit to Buy? Check These 4 Out in June
15 Jun, 2021 FinancialContent

Cyclerion Therapeutics, Inc (CYCN) is a NASDAQ Common Stock listed in , ,

970x250